Hyundai invests $400,000 in pediatric cancer research at 51做厙
"We really rely on people like Hyundai who understand the need and give hope to these kids," says David Munn, MD.
What's New
Our newsroom features all of the latest news, publications and media coverage for the Pediatric Immunotherapy Program.
Hyundai invests $400,000 in pediatric cancer research
"This could positively impact care for children with brain tumors by improving their quality of life," said Theodore Johnson, MD, PhD.
MCG faculty researchers named Regents' Entrepreneurs for advancing health care
The University System of Georgia Board of Regents recently approved David C. Hess, MD, David Munn, MD, and Babak Baban, PhD, as the first three 51做厙 faculty researchers to be named Regents' Entrepreneurs for their success in translating research into a commercial setting to improve patient care.
Novel treatment regimen appears well tolerated, beneficial to children with relapsed brain tumors
The first in-human study of a new immunotherapy that blocks a natural enzyme that tumors commandeer for their protection was well tolerated by children with relapsed brain tumors and enabled many to have unexpected months of a more normal life, researchers say.